Activation of type 2 cannabinoid receptor (CB2R) by selective agonists regulates the deposition and remodelling of the extracellular matrix
Authors:
- 1 November 2017
- journal article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 95, 1704-1709
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Prevention of Ocular Scarring Post Glaucoma Filtration Surgery Using the Inflammatory Cell and Platelet Binding Modulator Saratin in a Rabbit ModelPLOS ONE, 2012
- Is lipid signaling through cannabinoid 2 receptors part of a protective system?Progress in Lipid Research, 2011
- Cannabinoid receptor type 2 (CB2) deficiency alters atherosclerotic lesion formation in hyperlipidemic Ldlr-null miceAtherosclerosis, 2010
- SPARC Deficiency Results in Improved Surgical Survival in a Novel Mouse Model of Glaucoma Filtration SurgeryPLOS ONE, 2010
- Effects of Pirfenidone on Proliferation, Migration, and Collagen Contraction of Human Tenon’s Fibroblasts In VitroInvestigative Ophthalmology & Visual Science, 2009
- Emerging role of the cannabinoid receptor CB2in immune regulation: therapeutic prospects for neuroinflammationExpert Reviews in Molecular Medicine, 2009
- Lovastatin Inhibits TGF-β–Induced Myofibroblast Transdifferentiation in Human Tenon FibroblastsInvestigative Ophthalmology & Visual Science, 2008
- TRAF6 Mediates Smad-Independent Activation of JNK and p38 by TGF-βMolecular Cell, 2008
- Induction by Latanoprost of Collagen Gel Contraction Mediated by Human Tenon Fibroblasts: Role of Intracellular Signaling MoleculesInvestigative Ophthalmology & Visual Science, 2008
- Cannabinol Derivatives: Binding to Cannabinoid Receptors and Inhibition of AdenylylcyclaseJournal of Medicinal Chemistry, 1997